BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28971229)

  • 1. Role of the guanine nucleotide binding protein, Gα
    Lamberts JT; Rosenthal LD; Jutkiewicz EM; Traynor JR
    Psychopharmacology (Berl); 2018 Jan; 235(1):71-82. PubMed ID: 28971229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.
    Lamberts JT; Smith CE; Li MH; Ingram SL; Neubig RR; Traynor JR
    J Neurosci; 2013 Mar; 33(10):4369-77. PubMed ID: 23467353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice.
    Divin MF; Holden Ko MC; Traynor JR
    Eur J Pharmacol; 2008 Mar; 583(1):48-55. PubMed ID: 18275956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
    Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
    Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine tolerance and dependence in the nociceptin receptor knockout mice.
    Mamiya T; Noda Y; Ren X; Nagai T; Takeshima H; Ukai M; Nabeshima T
    J Neural Transm (Vienna); 2001; 108(12):1349-61. PubMed ID: 11810400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception.
    Li JX; McMahon LR; Gerak LR; Becker GL; France CP
    Psychopharmacology (Berl); 2008 Aug; 199(2):199-208. PubMed ID: 18470505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence.
    Ueda H; Inoue M; Takeshima H; Iwasawa Y
    J Neurosci; 2000 Oct; 20(20):7640-7. PubMed ID: 11027224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-
    Yadlapalli JSK; Bommagani SB; Mahelona RD; Wan A; Gannon BM; Penthala NR; Dobretsov M; Crooks PA; Fantegrossi WE
    Pharmacol Res Perspect; 2018 Jul; 6(4):e00403. PubMed ID: 29930811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
    Wang D; Raehal KM; Bilsky EJ; Sadée W
    J Neurochem; 2001 Jun; 77(6):1590-600. PubMed ID: 11413242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence.
    Inoue M; Mishina M; Ueda H
    J Neurosci; 2003 Jul; 23(16):6529-36. PubMed ID: 12878694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics.
    Raehal KM; Bohn LM
    Neuropharmacology; 2011 Jan; 60(1):58-65. PubMed ID: 20713067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats.
    Cook CD; Barrett AC; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):93-104. PubMed ID: 11041321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.
    Glück L; Loktev A; Moulédous L; Mollereau C; Law PY; Schulz S
    Biol Psychiatry; 2014 Nov; 76(10):767-74. PubMed ID: 24629717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ATPM-ET, a novel κ agonist with partial μ activity, on physical dependence and behavior sensitization in mice.
    SUN JF; WANG YH; LI FY; LU G; TAO YM; CHENG Y; CHEN J; XU XJ; CHI ZQ; NEUMEYER JL; ZHANG A; LIU JG
    Acta Pharmacol Sin; 2010 Dec; 31(12):1547-52. PubMed ID: 21102484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.
    Fitting S; Stevens DL; Khan FA; Scoggins KL; Enga RM; Beardsley PM; Knapp PE; Dewey WL; Hauser KF
    J Pharmacol Exp Ther; 2016 Jan; 356(1):96-105. PubMed ID: 26542403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo activation of a mutant mu-opioid receptor by naltrexone produces a potent analgesic effect but no tolerance: role of mu-receptor activation and delta-receptor blockade in morphine tolerance.
    Roy S; Guo X; Kelschenbach J; Liu Y; Loh HH
    J Neurosci; 2005 Mar; 25(12):3229-33. PubMed ID: 15788780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal.
    Grim TW; Schmid CL; Stahl EL; Pantouli F; Ho JH; Acevedo-Canabal A; Kennedy NM; Cameron MD; Bannister TD; Bohn LM
    Neuropsychopharmacology; 2020 Jan; 45(2):416-425. PubMed ID: 31443104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.